Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
28.48
-0.23 (-0.80%)
At close: Feb 12, 2026

SHA:688443 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,4152,0352,89249.2814.1542.48
Trading Asset Securities
901.56412.5827.71237.36427.1113.78
Cash & Short-Term Investments
2,3162,4482,920286.64441.2556.27
Cash Growth
-9.55%-16.16%918.65%-35.04%684.19%163.06%
Accounts Receivable
29.7812.01---0.63
Other Receivables
3.671.380-1.533.66
Receivables
33.4513.380-1.534.29
Inventory
73.950.1555.4556.3333.6615.85
Other Current Assets
98.83110.5956.5656.0352.7630.38
Total Current Assets
2,5222,6223,032399529.2106.79
Property, Plant & Equipment
458.09441.55487.82487.75327.83267.8
Other Intangible Assets
42.7343.5943.5445.0845.9248.94
Long-Term Deferred Charges
16.1425.1627.9225.5123.5124.96
Other Long-Term Assets
5.6613.263.464.7776.3649.68
Total Assets
3,0453,1463,595962.111,003498.17
Accounts Payable
95.1367.0683.0467.8446.6133.31
Accrued Expenses
45.2863.0337.7429.7124.2914.27
Short-Term Debt
--0.63---
Current Portion of Long-Term Debt
166.3826.24-5.30.90.9
Current Portion of Leases
-12.1310.077.646.51-
Other Current Liabilities
13.185.825.415.877.7431.42
Total Current Liabilities
332.26174.29136.87126.3786.01479.91
Long-Term Debt
872.88786.13608.48738.59535.55349.66
Long-Term Leases
7.9812.6321.8230.3728.65-
Long-Term Unearned Revenue
43.9446.6243.237.6935.5534.15
Other Long-Term Liabilities
----5.089.51
Total Liabilities
1,2571,020810.36933.03690.84873.22
Common Stock
366.68366.68366.68275275200
Additional Paid-In Capital
4,1924,1924,038573.29279.82249.98
Retained Earnings
-2,750-2,418-1,621-819.21-242.84-825.04
Treasury Stock
-20.3-14.67----
Shareholders' Equity
1,7882,1262,78429.08311.98-375.05
Total Liabilities & Equity
3,0453,1463,595962.111,003498.17
Total Debt
1,047837.13640.99781.91571.6350.57
Net Cash (Debt)
1,2691,6112,279-495.27-130.35-294.3
Net Cash Growth
-29.33%-29.31%----
Net Cash Per Share
3.464.387.11-1.80-0.47-
Filing Date Shares Outstanding
366.68366.68366.68275275-
Total Common Shares Outstanding
366.68366.68366.68275275-
Working Capital
2,1902,4482,895272.63443.19-373.12
Book Value Per Share
4.885.807.590.111.13-
Tangible Book Value
1,7452,0822,741-15.99266.06-423.99
Tangible Book Value Per Share
4.765.687.47-0.060.97-
Buildings
-115.03114.98105.8999.7799.77
Machinery
-516.53457.63302.65261.93214.75
Construction In Progress
-6.7452.18164.8218.279.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.